(Q34568319)

3 August 2017

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis (English)

1 reference

3 August 2017

0 references

0 references

1 reference

0 references

Laurent Nicod

7

0 references

Denis Hochstrasser

9

object named as

Denis Hochstrasser

1 reference

3 August 2017

Nicolas Vuilleumier

1

1 reference

3 August 2017

Michel F Rossier

2

1 reference

3 August 2017

Alberto Chiappe

3

1 reference

3 August 2017

Florence Degoumois

4

1 reference

3 August 2017

Pierre Dayer

5

1 reference

3 August 2017

Bernadette Mermillod

6

1 reference

3 August 2017

Jules Desmeules

8

1 reference

3 August 2017

27 April 2006

1 reference

European Journal of Clinical Pharmacology

3 August 2017

1 reference

3 August 2017

62

1 reference

3 August 2017

423-429

1 reference

3 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-006-0111-5

3 August 2017

0 references

cites work

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0111-5

Preliminary phenotypic map of chromosome 4p16 based on 4p deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0111-5

Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0111-5

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0111-5

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0111-5

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0111-5

Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population

21 January 2018

1 reference

12 December 2020

Isoniazid toxicity presenting as seizures and metabolic acidosis.

1 reference

12 December 2020

Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene

1 reference

12 December 2020

Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin

1 reference

12 December 2020

A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid

1 reference

12 December 2020

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

1 reference

12 December 2020

Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity

1 reference

12 December 2020

Risk Factors for Isoniazid (INH)-Induced Liver Dysfunction

1 reference

12 December 2020

Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society

1 reference

12 December 2020

Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

1 reference

12 December 2020

Pitfalls in N-acetyltransferase 2 genotyping.

1 reference

12 December 2020

Cytochrome P450 2E1: its clinical and toxicological role

1 reference

12 December 2020

N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism

1 reference

12 December 2020

Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients.

1 reference

12 December 2020

1 reference

12 December 2020

Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid

1 reference

12 December 2020

Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype

1 reference

12 December 2020

Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis

1 reference

12 December 2020

Acute isoniazid neurotoxicity during preventive therapy

1 reference

12 December 2020

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

1 reference

12 December 2020

Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments.

1 reference

12 December 2020

A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.

1 reference

12 December 2020

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

1 reference

12 December 2020

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

1 reference

12 December 2020

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

1 reference

12 December 2020

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

1 reference

12 December 2020

In vivo modulation of CYP enzymes by quinidine and rifampin

1 reference

12 December 2020

Isoniazid-associated hepatitis in 114 patients

1 reference

12 December 2020

Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status

1 reference

12 December 2020

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

12 December 2020

Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations

1 reference

12 December 2020

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity

1 reference

12 December 2020

Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?

1 reference

12 December 2020

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

1 reference

12 December 2020

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

1 reference

12 December 2020

Cytochrome P-4502E1: its physiological and pathological role

1 reference

12 December 2020

10.1007/S00228-006-0111-5

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference